Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

FLGT

Fulgent Genetics (FLGT)

Fulgent Genetics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:FLGT
DateTimeSourceHeadlineSymbolCompany
06/04/20244:57PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FLGTFulgent Genetics Inc
06/04/20244:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FLGTFulgent Genetics Inc
06/03/20248:00AMBusiness WireFulgent Data at ASCO 2024 Highlights Antitumor Activity from Lead Therapeutic Oncology Candidate, FID-007, in Head and Neck CancerNASDAQ:FLGTFulgent Genetics Inc
05/28/20244:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FLGTFulgent Genetics Inc
05/28/20244:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FLGTFulgent Genetics Inc
05/24/20248:00AMBusiness WireFulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2024 Annual MeetingNASDAQ:FLGTFulgent Genetics Inc
05/20/20246:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FLGTFulgent Genetics Inc
05/20/20246:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FLGTFulgent Genetics Inc
05/16/20244:29PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FLGTFulgent Genetics Inc
05/14/20244:05PMBusiness WireMoffitt Cancer Center and Fulgent Pharma Join Forces to Revolutionize Cancer TherapeuticsNASDAQ:FLGTFulgent Genetics Inc
05/07/20244:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FLGTFulgent Genetics Inc
05/03/20247:00AMBusiness WireFulgent Reports First Quarter 2024 Financial ResultsNASDAQ:FLGTFulgent Genetics Inc
04/11/20244:05PMBusiness WireFulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024NASDAQ:FLGTFulgent Genetics Inc
03/05/20244:28PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FLGTFulgent Genetics Inc
03/05/20244:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FLGTFulgent Genetics Inc
02/28/20247:12PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FLGTFulgent Genetics Inc
02/28/20247:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FLGTFulgent Genetics Inc
02/28/20247:08AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FLGTFulgent Genetics Inc
02/28/20247:00AMBusiness WireFulgent Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:FLGTFulgent Genetics Inc
02/27/20246:52PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FLGTFulgent Genetics Inc
02/27/20246:50PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FLGTFulgent Genetics Inc
02/13/20248:00AMBusiness WireFulgent Genetics to Announce Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 28, 2024NASDAQ:FLGTFulgent Genetics Inc
02/09/20246:09PMEdgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNASDAQ:FLGTFulgent Genetics Inc
02/09/20248:31AMPR Newswire (US)Cord Blood Registry® (CBR®) by CooperSurgical® and Fulgent Genetics Launch Innovative Genetic TestingNASDAQ:FLGTFulgent Genetics Inc
02/06/20247:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FLGTFulgent Genetics Inc
02/01/20244:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FLGTFulgent Genetics Inc
01/30/20244:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FLGTFulgent Genetics Inc
01/30/20244:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FLGTFulgent Genetics Inc
12/13/20238:49PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FLGTFulgent Genetics Inc
12/12/20239:43PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FLGTFulgent Genetics Inc
 Showing the most relevant articles for your search:NASDAQ:FLGT